tiprankstipranks
Trending News
More News >
Prime Medicine, Inc. (PRME)
NASDAQ:PRME
US Market

Prime Medicine, Inc. (PRME) Income Statement

Compare
838 Followers

Prime Medicine, Inc. Income Statement

Last quarter (Q3 2025), Prime Medicine, Inc.'s total revenue was $1.23M, an increase of 486.12% from the same quarter last year. In Q3, Prime Medicine, Inc.'s net income was $-50.58M. See Prime Medicine, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.98M$ 0.00$ 0.00$ 0.00$ 5.21M
Gross Profit
$ 2.98M$ 0.00$ 0.00$ 0.00$ 2.23M
Operating Expenses
$ 205.45M$ 204.79M$ 116.54M$ 84.47M$ 3.16M
Depreciation and Amortization
$ 6.13M$ 4.65M$ 2.22M$ 568.00K$ 43.00K
EBITDA
$ -196.34M$ -186.64M$ -114.32M$ -83.91M$ -889.00K
Operating Income
$ -202.47M$ -204.79M$ -116.54M$ -84.47M$ -932.00K
Other Income/Expenses
$ 6.58M$ 6.38M$ -6.22M$ -81.38M$ -611.00K
Pretax Income
$ -195.88M$ -198.41M$ -122.77M$ -165.85M$ -1.54M
Net Income
$ -195.88M$ -198.13M$ -121.82M$ -165.37M$ -3.41M
Per Share Metrics
Basic EPS
$ -1.65$ -2.18$ -1.46$ -1.92$ -0.05
Diluted EPS
$ -1.65$ -2.18$ -1.46$ -1.92$ -0.05
Weighted Average Shares Outstanding
118.60M 90.97M 97.21M 95.73M 95.73M
Weighted Average Shares Outstanding (Diluted)
118.60M 90.97M 97.21M 95.73M 95.73M
Currency in USD

Prime Medicine, Inc. Earnings and Revenue History